Effect on health outcomes of a community-based medication therapy management program for seniors with limited incomes

American Journal of Health-System Pharmacy

Volumn 63, Issue 4, 2006, Pages 372-379

  Smith, Scott R ^a,b   Catellier, Diane J ^c   Conlisk, Elizabeth A ^d   Upchurch, Gina A ^b,c,e  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d HAMPSHIRE COLLEGE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADL DISABILITY; AFRICAN AMERICAN; AGED; AGING; AMBULATORY CARE; ANXIETY DISORDER; ARTHRITIS; CHRONIC DISEASE; COMMUNITY PROGRAM; DEPRESSION; DIABETES MELLITUS; EMERGENCY WARD; FEMALE; FUNCTIONAL STATUS; GERIATRIC CARE; HEALTH CARE QUALITY; HEART DISEASE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NOTE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SOCIAL SUPPORT; STATISTICAL ANALYSIS; UNITED STATES;

EID: 32644448456     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050089     Document Type: Note

References (36)

1. Kaufman DW, Kelly JP, Rosenberg L et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002; 287:337-44.
2. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001; 16:793-9.
3. Tamblyn R, Laprise R, Hanley JA et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001; 285:421-9.
4. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003; 289:1107-16.
5. Steinbrook R. The prescription-drug problem. N Engl J Med. 2002; 346:790.
6. Upchurch GA, Menon MP, Levin KS et al. Prescription assistance for older adults with limited incomes: client and program characteristics. J Pharm Technol. 2001; 17:6-12.
7. Catellier DJ, Conlisk EA, Vitt CM et al. A community-based pharmaceutical care program for the elderly reduces emergency room and hospital use. N C Med J. 2000; 61:99-104.
8. Green LW, Kreuter MW. Health promotion planning, an educational and ecological approach, 4th ed. New York: McGraw-Hill; 2004.
9. Gielen CG, McDonald EM. Using the PRECEDE-PROCEED planning model to apply health behavior theories. In: Glanz K, Rimer BK, Lewis FM, eds. Health behavior and health education. San Francisco: Jossey-Bass; 2002.
10. Glanz K, Rimer BK. Theory at a glance: a guide for health promotion practice. Bethesda, MD: National Cancer Institute, 1995; NIH publication no. 95-3896.
11. Fick DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003; 163:2716-24.
12. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997; 157:1531-6.
13. Duke University Center for the Study of Aging and Human Development. Multidimensional functional assessment: the OARS methodology. Durham, NC: Duke Univ. Press; 1978.
14. Diggle PJ, Liang K, Zeger SL. Analysis of longitudinal data. New York: Oxford Univ. Press; 1994.
15. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute; 1999.
16. Rubin DB. Inference and missing data. Biometrika. 1976; 63:581-92.
17. Smith SR, Golin CE, Reif S. Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications. Am J Health-Syst Pharm. 2004; 61:1120-9.
18. Weinberger M, Murray MD, Marrero DG et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002; 288:1594-602.
19. Indritz ME, Artz MB. Value added to health by pharmacists. Soc Sci Med. 1999; 48:647-60.
20. Zermansky AG, Petty DR, Raynor DK et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001; 323:1340-3.
21. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996; 100:428-37.
22. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
23. Kucukarslan SN, Peters M, Mlynarek M et al. Pharmacists on Founding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003; 163:2014-8.
24. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995; 41:469-72.
25. Munroe WP, Kunz K, Dalmady-Israel C et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997; 19:113-23.
26. Gattis WA, Hasselblad V, Whellan DJ et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med. 1999; 159:1939-45.
27. Bogden PE, Abbott RD, Williamson P et al. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med. 1998; 13:740-5.
28. Bogden PE, Koontz LM, Williamson P et al. The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med. 1997; 12:158-64.
29. Berringer R, Shibley MC, Gary CC et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999; 39:791-7.
30. Faulkner MA, Wadibia EC, Lucas BD et al. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000; 20:410-6.
31. Lee M, Kemp JA, Canning A et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999; 159:2312-6.
32. Bouvy ML, Heerdink ER, Urquhart J et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003; 9:404-11.
33. Sturgess IK, McElnay JC, Hughes CM et al. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003; 25:218-26.
34. Tsuyuki RT, Johnson JA, Teo KK et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002; 162:1149-55.
35. Williams ME, Pulliam CC, Hunter R et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004; 52:93-8.
36. Sellors J, Kaczorowski J, Sellors C et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J. 2003; 129:17-22.